These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22629005)

  • 1. CA 19-9 as a serum marker in urothelial carcinoma.
    Pall M; Iqbal J; Singh SK; Rana SV
    Urol Ann; 2012 May; 4(2):98-101. PubMed ID: 22629005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of urinary CA19-9 levels in urothelial cancer--assessment of its role in diagnosis].
    Noto K; Fujime M; Isobe H; Wakumato Y; Kawachi Y
    Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):406-13. PubMed ID: 9125864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of CA19-9 in predicting the prognosis of urothelial carcinoma: a hospital based study from Nepal.
    Jha DK; Mittal A; Gupta SP; Sathian B
    Asian Pac J Cancer Prev; 2013; 14(7):4067-9. PubMed ID: 23991954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary level of CA19-9 as a tumor marker in urothelial carcinoma of the bladder.
    Pal K; Roy S; Mondal SA; Chatterjee U; Tiwari P; Bera M
    Urol J; 2011; 8(3):203-8. PubMed ID: 21910099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.
    Yaegashi H; Izumi K; Kadomoto S; Naito R; Makino T; Iwamoto H; Nohara T; Shigehara K; Kadono Y; Mizokami A
    Anticancer Res; 2019 Jan; 39(1):375-380. PubMed ID: 30591483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
    Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
    Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
    Ahmadi H; Djaladat H; Cai J; Miranda G; Daneshmand S
    Urol Oncol; 2014 Jul; 32(5):648-56. PubMed ID: 24680660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CA19-9 as a tumor marker in urothelial malignancy.
    Chuang CK; Liao SK
    Scand J Urol Nephrol; 2004; 38(5):359-65. PubMed ID: 15764245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
    Murakami M; Nagai Y; Tenjin A; Tanaka Y
    Endocr J; 2018 Jun; 65(6):639-643. PubMed ID: 29643268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA19-9 is a significant prognostic marker of patients with stage III gastric cancer.
    Kambara Y; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Yuasa N
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1918-1924. PubMed ID: 32814681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Albumin-Bilirubin Grade as a Useful Prognostic Indicator in Patients With Pancreatic Cancer.
    Yagyu T; Saito H; Sakamoto T; Uchinaka EI; Morimoto M; Amisaki M; Watanabe J; Tokuyasu N; Honjo S; Ashida K; Fujiwara Y
    Anticancer Res; 2019 Mar; 39(3):1441-1446. PubMed ID: 30842180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and C-reactive protein.
    La Greca G; Sofia M; Lombardo R; Latteri S; Ricotta A; Puleo S; Russello D
    World J Gastroenterol; 2012 Aug; 18(31):4150-5. PubMed ID: 22919247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigen 19-9 as a prognostic biomarker in pancreatic neuroendocrine tumors.
    Luo G; Jin K; Cheng H; Liu C; Guo M; Lu Y; Yang C; Xu J; Wang W; Gao H; Zhang S; Long J; Xu J; Ni Q; Chen J; Yu X
    Oncol Lett; 2017 Dec; 14(6):6795-6800. PubMed ID: 29163700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA19-9 as a serum marker for poor prognosis in urothelial carcinoma.
    Sashide K; Isobe H; Wakumoto Y; Hanazawa K; Fujita K; Fujime M
    Urol Int; 2004; 72(2):112-7. PubMed ID: 14963350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.
    Luo G; Guo M; Jin K; Liu Z; Liu C; Cheng H; Lu Y; Long J; Liu L; Xu J; Ni Q; Yu X
    Pancreatology; 2016; 16(6):1057-1062. PubMed ID: 27692554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Hackert T; Hinz U; Hartwig W; Büchler MW; Werner J
    Br J Surg; 2011 Jan; 98(1):104-10. PubMed ID: 20949535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer.
    Abe T; Koi C; Kohi S; Song KB; Tamura K; Macgregor-Das A; Kitaoka N; Chuidian M; Ford M; Dbouk M; Borges M; He J; Burkhart R; Wolfgang CL; Klein AP; Eshleman JR; Hruban RH; Canto MI; Goggins M
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1161-1169.e5. PubMed ID: 31676359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
    Safi F; Roscher R; Beger HG
    Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.